CA1063516A - Pharmaceutical preparations for the treatment of coronary heart diseases - Google Patents

Pharmaceutical preparations for the treatment of coronary heart diseases

Info

Publication number
CA1063516A
CA1063516A CA242,899A CA242899A CA1063516A CA 1063516 A CA1063516 A CA 1063516A CA 242899 A CA242899 A CA 242899A CA 1063516 A CA1063516 A CA 1063516A
Authority
CA
Canada
Prior art keywords
propanol
isopropylamino
phenyl
used pharmaceutically
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA242,899A
Other languages
English (en)
French (fr)
Inventor
Peter R. Imhof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of CA1063516A publication Critical patent/CA1063516A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA242,899A 1975-01-06 1976-01-02 Pharmaceutical preparations for the treatment of coronary heart diseases Expired CA1063516A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7175 1975-01-06

Publications (1)

Publication Number Publication Date
CA1063516A true CA1063516A (en) 1979-10-02

Family

ID=4178628

Family Applications (1)

Application Number Title Priority Date Filing Date
CA242,899A Expired CA1063516A (en) 1975-01-06 1976-01-02 Pharmaceutical preparations for the treatment of coronary heart diseases

Country Status (14)

Country Link
JP (1) JPS5191337A (es)
AU (1) AU499140B2 (es)
BE (1) BE837293A (es)
CA (1) CA1063516A (es)
DE (1) DE2600069A1 (es)
FR (1) FR2296430A1 (es)
GB (1) GB1510370A (es)
HK (1) HK49680A (es)
IE (1) IE42766B1 (es)
IL (1) IL48785A (es)
MY (1) MY8100159A (es)
NL (1) NL7600045A (es)
NZ (1) NZ179623A (es)
ZA (2) ZA7628B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981563A (en) * 1995-04-28 1999-11-09 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019006A1 (de) * 1979-05-14 1980-11-26 Ciba-Geigy Ag Pharmazeutische Präparate, die als Wirkstoff ein substituiertes Pyrazolidinderivat enthalten, deren Verwendung und Verfahren zu ihrer Herstellung
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
TW284688B (es) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL37700A (en) * 1970-10-02 1975-05-22 Ciba Geigy Ag Pharmaceutical preparations containing an aryloxypropanolamine derivative or an arylethanolamine derivative

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981563A (en) * 1995-04-28 1999-11-09 Zonagen, Inc. Methods and formulations for modulating the human sexual response
US6051594A (en) * 1995-04-28 2000-04-18 Zonagen, Inc. Methods and formulations for modulating the human sexual response
US6100286A (en) * 1995-04-28 2000-08-08 Zonagen, Inc. Methods and formulations for modulating the human sexual response
US6124337A (en) * 1995-04-28 2000-09-26 Zonagen, Inc. Methods and formulations for modulating the human sexual response
US6166061A (en) * 1995-04-28 2000-12-26 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Also Published As

Publication number Publication date
FR2296430B1 (es) 1978-11-10
AU499140B2 (en) 1979-04-05
IE42766L (en) 1976-07-06
ZA7626B (en) 1976-12-29
AU1000276A (en) 1977-07-14
MY8100159A (en) 1981-12-31
ZA7628B (en) 1976-12-29
NZ179623A (en) 1978-03-06
HK49680A (en) 1980-09-12
IL48785A (en) 1978-08-31
FR2296430A1 (fr) 1976-07-30
IL48785A0 (en) 1976-03-31
NL7600045A (nl) 1976-07-08
BE837293A (fr) 1976-07-05
IE42766B1 (en) 1980-10-08
GB1510370A (en) 1978-05-10
JPS5191337A (es) 1976-08-10
DE2600069A1 (de) 1976-07-15

Similar Documents

Publication Publication Date Title
CZ9697A3 (en) Use of heterocyclic compound as dopamine-d3 ligands
US4071518A (en) Di-and tri-substituted 1,2,4-triazoles
US2937118A (en) Aminopyridine compositions
NO174772C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive piperazinylderivater
NL8802059A (nl) Esters en amiden van cyclische carbonzuren en cyclische alcoholen en aminen.
ES8104284A1 (es) Procedimiento para la preparacion de 3-amino-sidnoniminas
CA1063516A (en) Pharmaceutical preparations for the treatment of coronary heart diseases
NZ333369A (en) 7-(2-imidazolinylamino)quinoline compounds useful for treating respiratory, ocular and/or gastrointestinal disorders
JPS6230780A (ja) １，７−ナフチリジン誘導体及びこれを含有する薬剤
US5866574A (en) Pancreatitis remedy
US5739148A (en) 6-(2-Imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
US4161530A (en) Pharmaceutical combination preparations as hypnotics
US3600390A (en) Novel 5-phenyl imidazolidino(5,1-a)5h-quinazolines and process therefor
CA1063026A (en) Pharmaceutical preparation for hypnotics
JPS55118488A (en) Theobromine derivative and its preparation
KR20010107927A (ko) 면역 조절용 약학 조성물
US4440773A (en) Pyridylalkylenethiopridyl, -tetrahydropyridyl and -pyridinium compounds
ES482929A1 (es) Un procedimiento para la prepracion de alquiltiofenoxialqui-laminas.
US5532251A (en) Method of treating cardiac arrhythmia with 3-benzoyl-3, 7-diazabicyclo[3.3.1]nonane compounds
DE60113300T2 (de) Piperazinylcarbonylchinoline und isochinoline
FR2618435B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
NO162017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-aryl-alfa-pyridylalkansyrederivater.
US3885034A (en) Phenothiazine derivatives in the treatment of psychotic persons
JPS56120683A (en) Piperazine derivative of theophylline* its manufacture and therapeutic composition for respiratory disease
NL8200746A (nl) Verbinding met antitussive activiteit, werkwijze ter bereiding daarvan en toepassing.